Objective: This study describes the development and psychometric evaluation of HPV Clinical Trial Survey for Parents with Children Aged 9 to 15 (CTSP-HPV) using traditional instrument development methods and community engagement principles. Methods: An expert panel and parental input informed survey content and parents recommended study design changes (e.g., flyer wording). A convenience sample of 256 parents completed the final survey measuring parental willingness to consent to HPV clinical trial (CT) participation and other factors hypothesized to influence willingness (e.g., HPV vaccine benefits). Cronbach's a, Spearman correlations, and multiple linear regression were used to estimate internal consistency, convergent and discriminant validity, and predictively validity, respectively. Results: Internal reliability was confirmed for all scales (a ≥ 0.70.). Parental willingness was positively associated (p < 0.05) with trust in medical researchers, adolescent CT knowledge, HPV vaccine benefits, advantages of adolescent CTs (r range 0.33-0.42), supporting convergent validity. Moderate discriminant construct validity was also demonstrated. Regression results indicate reasonable predictive validity with the six scales accounting for 31% of the variance in parents' willingness. Conclusions: This instrument can inform interventions based on factors that influence parental willingness, which may lead to the eventual increase in trial participation. Further psychometric testing is warranted.
|Number of pages||8|
|Journal||Clinical and Translational Science|
|State||Published - Dec 1 2015|
Bibliographical noteFunding Information:
This work was supported with funding from the Patient-Centered Outcomes Research Institute (PCORI) under the following award number: CDRN-1306-04869 and the National Institutes of Health under award numbers U54-MD007593 and UL1-TR000445. We appreciate the research assistance from Lisa Sherden, Alaina Boyer, Paxton Montgomery, Chaunte Stubbs, and Tiffany Israel.
© 2015 Wiley Periodicals, Inc.
- Clinical trials
- Community engaged research
- Human papillomavirus
- Survey development
ASJC Scopus subject areas
- Neuroscience (all)
- Biochemistry, Genetics and Molecular Biology (all)
- Pharmacology, Toxicology and Pharmaceutics (all)